Bradford D. Dahms's Insider Trades & SAST Disclosures
Bradford D. Dahms's most recent trade in Theseus Pharmaceuticals Inc was a trade of 17,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bradford D. Dahms.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theseus Pharmaceuticals Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 17,500 | 17,500 | - | - | Restricted Stock Units | |
| Theseus Pharmaceuticals Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Bradford D. Dahms | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.66 per share. | 30 Nov 2022 | 1,502 | 6,142 | - | 6.7 | 10,000 | Common Stock |
| Theseus Pharmaceuticals Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Bradford D. Dahms | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.15 per share. | 21 Dec 2021 | 1,970 | 1,970 | - | 10.2 | 20,000 | Common Stock |
| Selecta Biosciences Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 38,000 | 38,000 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges